PLx Pharma - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsPLx Pharma

PLx Pharma(PLXP)

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

*Currency in USD

Company Revenue

Quarterly

Quarterly

Annual

Annual

Projections

*Quarterly sales USD (in millions)

Plot placeholder

Mock data
Subscribe for the real data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Vazalore	Aspirin	2013-01-14	2023-2033	Myocardial infarction , Acute coronary syndrome , Rheumatoid arthritis , Pain , Fever , Inflammation , Osteoarthritis , Rheumatic fever , Gout , Headache , Fatigue , Apnea , Myositis , Muscle cramp , Spasm , Tetanus , Muscle rigidity , Muscle spasticity , Cough , Anxiety disorders , Gastroesophageal reflux , Helicobacter infections , Stomach ulcer , Duodenal ulcer , Zollinger-ellison syndrome , Esophagitis , Heartburn , Postoperative pain , Hypercholesterolemia , Coronary artery disease , Hypertriglyceridemia , Hyperlipoproteinemias , Obstructive lung diseases

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

,

,

acquired immunodeficiency syndrome

,

postoperative pain

,

,

,

healthy volunteers/patients

healthy volunteers/patients

,

,

type 2 diabetes mellitus

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use